AbCellera Biologics Inc.
ABCL
$2.34
-$0.05-2.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.75% | -18.16% | -15.75% | -12.36% | -14.20% |
| Total Receivables | 43.10% | 68.87% | 48.22% | -30.93% | -37.74% |
| Inventory | -- | -- | -- | -49.00% | -- |
| Prepaid Expenses | -60.82% | -64.04% | -62.01% | 18.02% | 142.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -60.34% | -61.86% | 0.00% | 0.00% |
| Total Current Assets | -13.83% | -19.21% | -17.10% | -13.47% | -14.97% |
|
|
|||||
| Total Current Assets | -13.83% | -19.21% | -17.10% | -13.47% | -14.97% |
| Net Property, Plant & Equipment | 18.33% | 19.50% | 22.82% | 31.26% | 32.42% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -65.03% | -57.63% | -32.42% | -7.85% | -8.42% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.43% | 177.34% | -1.15% | 74.47% | 11.62% |
| Total Assets | -8.57% | -7.89% | -8.11% | -2.32% | -3.43% |
|
|
|||||
| Total Accounts Payable | 20.09% | 99.60% | 26.44% | 53.15% | 92.90% |
| Total Accrued Expenses | 8.67% | -36.56% | -37.34% | -41.73% | -70.13% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.96% | -8.02% | -5.88% | -5.74% | 10.30% |
| Total Finance Division Other Current Liabilities | -61.77% | -56.73% | -60.18% | 13.60% | 6.15% |
| Total Other Current Liabilities | -61.77% | -56.73% | -60.18% | 13.60% | 6.15% |
| Total Current Liabilities | -35.63% | -27.82% | -40.81% | 17.07% | 0.59% |
|
|
|||||
| Total Current Liabilities | -35.63% | -27.82% | -40.81% | 17.07% | 0.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.71% | -11.85% | -14.89% | -11.89% | -7.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.82% | 17.29% | 13.30% | 30.73% | 29.21% |
| Total Liabilities | -9.32% | -4.46% | -11.93% | 15.12% | 9.15% |
|
|
|||||
| Common Stock & APIC | 7.92% | 8.27% | 8.28% | 8.26% | 8.13% |
| Retained Earnings | -58.21% | -53.77% | -43.12% | -38.05% | -34.35% |
| Treasury Stock & Other | -154.53% | 15.62% | -9.16% | 10.14% | -23.65% |
| Total Common Equity | -8.35% | -8.85% | -7.02% | -6.50% | -6.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.35% | -8.85% | -7.02% | -6.50% | -6.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.35% | -8.85% | -7.02% | -6.50% | -6.56% |
|
|
|||||
